U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H29N4O12P4.Sm
Molecular Weight 698.1954
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DOTMP SM-153

SMILES

[153Sm+3].OP(O)(=O)CN1CCN(CP(O)([O-])=O)CCN(CP(O)([O-])=O)CCN(CP(O)([O-])=O)CC1

InChI

InChIKey=LNBUCNBAQQFTBL-GJNDDOAHSA-K
InChI=1S/C12H32N4O12P4.Sm/c17-29(18,19)9-13-1-2-14(10-30(20,21)22)5-6-16(12-32(26,27)28)8-7-15(4-3-13)11-31(23,24)25;/h1-12H2,(H2,17,18,19)(H2,20,21,22)(H2,23,24,25)(H2,26,27,28);/q;+3/p-3/i;1+3

HIDE SMILES / InChI

Molecular Formula Sm
Molecular Weight 152.9221
Charge 3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C12H29N4O12P4
Molecular Weight 545.2733
Charge -3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

SAMARIUM SM-153 is a β- and γ-emitter with a physical half-life around 46.8 hours. Sm-153 treatment is recommended for patients with multiple bone metastases with the osteoblastic component, regardless of the primary tumor’s location. This compound was used in prostate cancer. It was shown that the small influence of Sm-153 on hematological parameters in patients treated with Sm-153, because of the high affinity of Sm-153 to osteoblastic metastases, and of the effect of low concentration of radionuclide in healthy bone tissue.

Approval Year

PubMed

PubMed

TitleDatePubMed
The influence of Sm-153 therapy on bone marrow function.
2016
Effect of Au-197 nanoparticles along with Sm-153 radiopharmaceutical in prostate cancer from simulation method.
2019 Mar

Sample Use Guides

118 patients received single doses of placebo or Sm-153 of dose 0.5 mCi/kg or 1.0 mCi/kg
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Sat Dec 16 14:39:35 GMT 2023
Edited
by admin
on Sat Dec 16 14:39:35 GMT 2023
Record UNII
S5NN2E9ZKF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DOTMP SM-153
Common Name English
CYCLOSAM
Brand Name English
SM-153-DOTMP
Common Name English
153SM-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10- TETRAMETHYLENE-PHOSPHONIC ACID
Common Name English
SAMARATE(5-)-153SM, ((((1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAYL-.KAPPA.N1,.KAPPA.N4,.KAPPA.N7,.KAPPA.N10)TETRAKIS(METHYLENE))TETRAKIS(PHOSPHONATO-.KAPPA.O))(8-))-, PENTAHYDROGEN
Systematic Name English
SAMARIUM-153 DOTMP
Common Name English
153SM-DOTMP
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 773120
Created by admin on Sat Dec 16 14:39:35 GMT 2023 , Edited by admin on Sat Dec 16 14:39:35 GMT 2023
Code System Code Type Description
CAS
633308-21-1
Created by admin on Sat Dec 16 14:39:35 GMT 2023 , Edited by admin on Sat Dec 16 14:39:35 GMT 2023
PRIMARY
NCI_THESAURUS
C165558
Created by admin on Sat Dec 16 14:39:35 GMT 2023 , Edited by admin on Sat Dec 16 14:39:35 GMT 2023
PRIMARY
FDA UNII
S5NN2E9ZKF
Created by admin on Sat Dec 16 14:39:35 GMT 2023 , Edited by admin on Sat Dec 16 14:39:35 GMT 2023
PRIMARY
PUBCHEM
54671408
Created by admin on Sat Dec 16 14:39:35 GMT 2023 , Edited by admin on Sat Dec 16 14:39:35 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY